Edition:
India

Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

111.70USD
25 Sep 2020
Change (% chg)

$2.51 (+2.30%)
Prev Close
$109.19
Open
$108.84
Day's High
$112.30
Day's Low
$108.39
Volume
313,849
Avg. Vol
367,228
52-wk High
$131.60
52-wk Low
$73.03

Select another date:

Tue, Sep 22 2020

Photo

Walmart to test drone delivery of COVID-19 test kits

Walmart Inc said on Tuesday it would run a pilot project to deliver self-collection test kits for coronavirus through automated drones at customers' doorsteps.

Breakingviews - Corona Capital: Testing, Flights, Football

NEW YORK/LONDON/HONG KONG (Reuters Breakingviews) - Corona Capital is a column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights.

Quest Diagnostics raises 2020 profit, revenue forecast

Quest Diagnostics on Thursday raised its full-year revenue and profit forecast, benefiting from growing demand for its non-COVID-19 testing services.

CORRECTED-Quest Diagnostics raises 2020 profit, revenue forecast

Sept 10 Quest Diagnostics on Thursday raised its full-year revenue and profit forecast, benefiting from growing demand for its non-COVID-19 testing services.

Florida cuts ties with Quest over 75,000 COVID-19 test results backlog

Florida on Tuesday cut ties with Quest Diagnostics Inc as the medical device maker failed to share the results of nearly 75,000 COVID-19 tests dating back to April with the state health department in a timely manner due to a technical issue.

Florida cuts ties with Quest over 75,000 COVID-19 test results backlog

Sept 1 Florida on Tuesday cut ties with Quest Diagnostics Inc as the medical device maker failed to share the results of nearly 75,000 COVID-19 tests dating back to April with the state health department in a timely manner due to a technical issue.

FACTBOX-Drugmakers rush to develop COVID-19 treatments

(Adds Sorrento; Updates AstraZeneca, Gilead, Regeneron, Roche, Eli Lilly) Aug 25 Drugmakers around the world are rushing to develop treatments for COVID-19, the fast-spreading respiratory disease caused by the novel coronavirus that has killed hundreds of thousands. Gilead Sciences Inc's remdesivir is at the forefront of the efforts to treat the disease, after it helped shorten hospital recovery times in a clinical trial. The following is a list of major companies that are d

CORRECTED-Delta partners with CVS Health for rapid COVID-19 tests

Aug 18 Delta Air Lines Inc said on Tuesday it has partnered with CVS Health Corp to use its rapid-response nasal-swab test to detect the novel coronavirus among its flight crew.

Quest medical lab sees COVID-19 test speed at 'acceptable' level by Sept

Quest Diagnostics Inc said on Thursday it expects to cut week-long turnaround times for COVID-19 tests by more than half to get to "acceptable" levels by September, responding to concerns that slow testing is hampering the U.S. response.

UPDATE 4-Quest medical lab sees COVID-19 test speed at 'acceptable' level by Sept

July 23 Quest Diagnostics Inc said on Thursday it expects to cut week-long turnaround times for COVID-19 tests by more than half to get to "acceptable" levels by September, responding to concerns that slow testing is hampering the U.S. response.

Select another date: